Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
NCT00767286 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2014-01-28
Summary
RATIONALE: Patient abstract not available
PURPOSE: Patient abstract not available
Conditions
Interventions
- DRUG
-
flutamide
- DRUG
-
goserelin acetate
- RADIATION
-
low-LET cobalt-60 gamma ray therapy
- RADIATION
-
low-LET photon therapy
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Radiation Therapy Oncology Group
lead NETWORK
Principal Investigators
-
Gerald E. Hanks, MD · Fox Chase Cancer Center
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Completion
- 2003-11-30
More Related Trials
-
Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer
NCT00032006 ·Status: COMPLETED ·Phase: PHASE2
-
Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
NCT00003124 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer
NCT00849082 ·Status: COMPLETED ·Phase: PHASE3
-
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
NCT00567580 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer
NCT00651326 ·Status: TERMINATED ·Phase: PHASE3
-
Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer
NCT00423475 ·Status: COMPLETED ·Phase: PHASE3
-
Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
NCT00528866 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer
NCT04894188 ·Status: RECRUITING ·Phase: NA
-
Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
NCT00003653 ·Status: COMPLETED ·Phase: PHASE3
-
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
NCT00936390 ·Status: COMPLETED ·Phase: PHASE3
-
Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
NCT00937768 ·Status: TERMINATED ·Phase: PHASE2
-
Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
NCT00003734 ·Status: UNKNOWN ·Phase: PHASE3
-
External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer
NCT00388804 ·Status: TERMINATED ·Phase: PHASE3
-
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
NCT00021450 ·Status: COMPLETED ·Phase: PHASE3
-
S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
NCT00028769 ·Status: COMPLETED ·Phase: PHASE2
-
Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
NCT00544830 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
NCT00023829 ·Status: COMPLETED ·Phase: PHASE3
-
SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
NCT00026377 ·Status: COMPLETED ·Phase: PHASE1
-
Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer
NCT00002881 ·Status: COMPLETED ·Phase: PHASE3
-
Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer
NCT02168062 ·Status: TERMINATED ·Phase: PHASE2
-
Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
NCT05352178 ·Status: RECRUITING ·Phase: PHASE3
-
Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer
NCT00170157 ·Status: COMPLETED ·Phase: PHASE2
-
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
NCT00589472 ·Status: COMPLETED ·Phase: PHASE2
-
Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer
NCT05212857 ·Status: UNKNOWN ·Phase: PHASE2
-
Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy
NCT00439751 ·Status: COMPLETED ·Phase: PHASE3